600763 通策医疗
2024/03 - 三个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入708,4425.03%2,846,5082,718,6122,780,7252,087,865
减:营业总成本492,6077.21%2,199,9662,029,1511,873,0831,452,287
    其中:营业成本392,2605.90%1,749,7541,609,0251,500,0001,144,870
               财务费用10,69599.46%49,58946,55323,02015,227
               资产减值损失------------
公允价值变动收益------------
投资收益12,32935.59%60,19338,30156,13438,863
    其中:对联营企业和合营企业的投资收益7,708207.67%34,80010,74812,39613,086
营业利润228,3191.47%711,922733,906974,891678,640
利润总额228,1991.54%708,858737,984974,584680,066
减:所得税费用24,271-10.78%130,434122,306188,434135,104
净利润203,9283.24%578,423615,678786,150544,962
减:非控股权益30,7137.52%77,94967,40983,34352,336
股东净利润173,2152.51%500,475548,269702,807492,625

市场价值指针
每股收益 (元) *0.5401.89%1.5601.7102.1901.540
每股派息 (元) *----0.435------
每股净资产 (元) *12.40114.27%11.86710.3258.9846.706
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容